Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 22/10/2026			5-day change	1st Jan Change
14.68 ^MXN	+2.09%		+6.53%	-17.94%

23/10	Genomma Lab Internacional, S.A.B. de C.V., Q3 2026 Earnings Call, Oct 22, 2026
21/10	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	14,313	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-18.09%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	18,504	17,979	17,546
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-16.81%	-2.84%	-2.41%
P/E	14.9x	12x	13.1x	11.7x	11.1x	7.54x	7.43x	6.65x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	1.02x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.4x	4.93x	0.6x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.8x	0.76x	0.72x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	1.04x	0.96x	0.88x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.56x	4.2x	3.85x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.99x	4.63x	4.23x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	12.9x	9.03x	8.17x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	7.78%	11.1%	12.2%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8003	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.45%	7.3%	9.82%
EPS ²	1.44	1.41	1.08	2.14	1.61	1.946	1.975	2.206
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	41.1%	54.2%	65.3%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	17,805	18,740	19,945
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,061	4,279	4,559
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,705	3,886	4,146
Net income ¹	1,451	1,397	1,031	2,137	1,607	1,951	2,058	2,285
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,190	3,666	3,233
Reference price ²	21.48	16.94	14.16	25.13	17.89	14.68	14.68	14.68
Nbr of stocks (in thousands)	10,06,240	9,94,639	9,29,461	9,24,946	9,76,728	9,75,033	-	-
Announcement Date	23/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	7.54x	1.04x	4.56x	5.45%	77Cr
ELI LILLY AND COMPANY	37.7x	13.43x	28.51x	0.52%	1,16500Cr
JOHNSON & JOHNSON	39.17x	6.59x	18.54x	1.99%	64TCr
ABBVIE INC.	36.4x	8.37x	17.27x	2.41%	50TCr
ROCHE HOLDING AG	20.97x	5.15x	12.78x	2.55%	38TCr
MERCK & CO., INC.	107.33x	5.99x	25.72x	2.31%	36TCr
NOVARTIS AG	21.95x	5.71x	14.04x	2.79%	30TCr
ASTRAZENECA PLC	22.67x	4.58x	13.09x	1.93%	27TCr
AMGEN INC.	28.38x	7.14x	12.79x	2.26%	24TCr
GILEAD SCIENCES, INC.	-45.82x	7.02x	27.23x	2.1%	19TCr
Average	27.63x	6.50x	17.45x	2.43%	40.56TCr
Weighted average by Cap.	35.72x	8.44x	20.73x	1.78%